Literature DB >> 15075327

Structure of shiga toxin type 2 (Stx2) from Escherichia coli O157:H7.

Marie E Fraser1, Masao Fujinaga, Maia M Cherney, Angela R Melton-Celsa, Edda M Twiddy, Alison D O'Brien, Michael N G James.   

Abstract

Several serotypes of Escherichia coli produce protein toxins closely related to Shiga toxin (Stx) from Shigella dysenteriae serotype 1. These Stx-producing E. coli cause outbreaks of hemorrhagic colitis and hemolytic uremic syndrome in humans, with the latter being more likely if the E. coli produce Stx2 than if they only produce Stx1. To investigate the differences among the Stxs, which are all AB(5) toxins, the crystal structure of Stx2 from E. coli O157:H7 was determined at 1.8-A resolution and compared with the known structure of Stx. Our major finding was that, in contrast to Stx, the active site of the A-subunit of Stx2 is accessible in the holotoxin, and a molecule of formic acid and a water molecule mimic the binding of the adenine base of the substrate. Further, the A-subunit adopts a different orientation with respect to the B-subunits in Stx2 than in Stx, due to interactions between the carboxyl termini of the B-subunits and neighboring regions of the A-subunit. Of the three types of receptor-binding sites in the B-pentamer, one has a different conformation in Stx2 than in Stx, and the carboxyl terminus of the A-subunit binds at another. Any of these structural differences might result in different mechanisms of action of the two toxins and the development of hemolytic uremic syndrome upon exposure to Stx2.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15075327     DOI: 10.1074/jbc.M401939200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  120 in total

1.  Adenovirus vector expressing Stx1/Stx2-neutralizing agent protects piglets infected with Escherichia coli O157:H7 against fatal systemic intoxication.

Authors:  Abhineet S Sheoran; Igor P Dmitriev; Elena A Kashentseva; Ocean Cohen; Jean Mukherjee; Michelle Debatis; Jonathan Shearer; Jacqueline M Tremblay; Gillian Beamer; David T Curiel; Charles B Shoemaker; Saul Tzipori
Journal:  Infect Immun       Date:  2014-11-03       Impact factor: 3.441

2.  Analyzing of expression of novel polypeptide complexes consisting of Shiga toxin B subunit and Adherence Fimbriae of Escherichia coli based on in silico modeling.

Authors:  Zeinab Noroozian; Mana Oloomi; Saeid Bouzari
Journal:  J Mol Model       Date:  2012-04-24       Impact factor: 1.810

3.  Baicalin inhibits the lethality of Shiga-like toxin 2 in mice.

Authors:  Jing Dong; Yong Zhang; Yutao Chen; Xiaodi Niu; Yu Zhang; Cheng Yang; Quan Wang; Xuemei Li; Xuming Deng
Journal:  Antimicrob Agents Chemother       Date:  2015-09-08       Impact factor: 5.191

4.  A Conserved Structural Motif Mediates Retrograde Trafficking of Shiga Toxin Types 1 and 2.

Authors:  Andrey S Selyunin; Somshuvra Mukhopadhyay
Journal:  Traffic       Date:  2015-11-02       Impact factor: 6.215

5.  Identification of amino acids critical for the cytotoxicity of Shiga toxin 1 and 2 in Saccharomyces cerevisiae.

Authors:  Rong Di; Eric Kyu; Varsha Shete; Hemalatha Saidasan; Peter C Kahn; Nilgun E Tumer
Journal:  Toxicon       Date:  2010-12-22       Impact factor: 3.033

6.  Evaluation of the anti-terminator Q933 gene as a marker for Escherichia coli O157:H7 with high Shiga toxin production.

Authors:  Aqeel Ahmad; Ludek Zurek
Journal:  Curr Microbiol       Date:  2006-09-12       Impact factor: 2.188

7.  Influence of Coulombic repulsion on the dissociation pathways and energetics of multiprotein complexes in the gas phase.

Authors:  Igor Sinelnikov; Elena N Kitova; John S Klassen
Journal:  J Am Soc Mass Spectrom       Date:  2007-01-03       Impact factor: 3.109

8.  Effects of single amino acid substitution on the dissociation of multiply charged multiprotein complexes in the gas phase.

Authors:  Igor Sinelnikov; Elena N Kitova; John S Klassen; Glen D Armstrong
Journal:  J Am Soc Mass Spectrom       Date:  2007-01-16       Impact factor: 3.109

9.  The 13C4 monoclonal antibody that neutralizes Shiga toxin Type 1 (Stx1) recognizes three regions on the Stx1 B subunit and prevents Stx1 from binding to its eukaryotic receptor globotriaosylceramide.

Authors:  Michael J Smith; Humberto M Carvalho; Angela R Melton-Celsa; Alison D O'Brien
Journal:  Infect Immun       Date:  2006-10-09       Impact factor: 3.441

10.  Intracellular d-Serine Accumulation Promotes Genetic Diversity via Modulated Induction of RecA in Enterohemorrhagic Escherichia coli.

Authors:  James P R Connolly; Andrew J Roe
Journal:  J Bacteriol       Date:  2016-11-18       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.